Stemexcel is a CRO company in the whole process of clinical trials, providing services including registration, project management, data management and statistical analysis, medical support and third-party services.Clinical staging covers phase I-III clinical trials of new drugs, post-marketing clinical trials of drugs, bioequivalence tests, clinical trials of medical devices and research projects.
Stemexcel is involved in the department of infectious diseases, oncology, rheumatology, immunology, vaccine, endocrinology, respiratory medicine, gastroenterology, cardio-cerebrovascular medicine, anesthesiology, neurology, neurosurgery, dermatology, orthopedics, etc.
Stem's main clients base involves foreign-funded enterprises, large domestic pharmaceutical groups and innovative pharmaceutical enterprises, and its service quality has won unanimous praise and word of mouth from customers. Stem expects to help the development of the pharmaceutical industry through high-quality services.
Stem always pays close attention to relevant national policies and industry trends. Based on the latest guidelines, Stem accurately grasps the key points and relevant requirements, develops overall clinical development strategies, and assists in the rapid launch of drugs.
Beijing Stemexcel Technology Co.,Ltd was founded in 2005, focusing on the whole process of clinical trial services and registration services. The company is headquartered in Beijing, several branch offices in Shanghai, Guangzhou, Tianjin, Changchun, Shenyang, Wuhan, Chengdu, Xi’an, etc, contact offices in U.S, South Korea.